A major goal pursued by Pylotum is to study the origin of H. pylori related gastric cancer to develop novel means of prevention, risk stratification, diagnosis and therapeutic interventions for gastric cancer patients. Our ongoing trials will help to determine the impact of H. pylori eradication on gastric cancer development as well as to identify novel biomarkers and future therapeutic targets to treat gastric tumors. An experienced international interdisciplinary team and a state-of-the-art infrastructure ensure the success of our research projects.
Funded by: Federal Ministry of Education and Research (BMBF) | Ministry of Science and Technology of the People’s Republic of China | Beijing Municipal Science and Technology Commission